Further investigation into its mechanism reveals that Melatonin modulates ACSL4 ubiquitination and influences ferroptosis by boosting MDM2 expression, thereby leading to its therapeutic efficacy in treating stroke. The gene discussed is MDM2; the disease is stroke disorder.